On July 23, 2022, the China Enterprise Evaluation Association released the "2021 China Top 500 New Economy Enterprises" list. China's Top 500 New Economy Enterprises is hosted by the China Enterprise Evaluation Association

Ginkgo Bioworks said on Monday that it has entered into a definitive agreement to acquire Zymergen in an all-stock deal.

Chinese sequencing tech company GeneMind Biosciences said earlier this month that its single-molecule DNA sequencer, GenoCare 1600 (originally developed by Direct Genomics), has been approved by China's National Medical Products Administration (NMPA) for clinical and diagnostic applications.

Recently, the Wondfo Biotech COVID-19 Antigen Detection Kit (Immunochromatography Method) was included in the WHO (World Health Organization) list for emergency use by the WHO, which can be purchased by other countries and regions.

PamGene International BV said on Thursday that it has obtained CE-IVD registration for its IOpener-NSCLC blood test to help guide immunotherapy in advanced-stage cancer patients.

The US Food and Drug Administration this week granted Emergency Use Authorization for a molecular SARS-CoV-2 test from Predicine.

The semi-annual report shows that Maccura spent 166 million CNY to complete the acquisition of 100% equity of Beijing Dawei Biotechnology Co., Ltd. (hereinafter referred to as " Dawei ").

Danaher's diversification of its business conglomerate has led to increased stability and second quarter revenue growth in the face of headwinds, company executives said on Thursday

Roche on Thursday reported its Diagnostics division revenues grew 10 percent year over year in the first half of the year but said that it expects the momentum from COVID-19 testing-related sales to slow throughout the rest of the year.

Recently, Wondfo's 2019-nCoV Antigen Test (Lateral Flow Method) is listed by WHO (World Health Organization) for emergency use listing (EUL), available for purchase in other countries and regions in worldwide.

Danaher subsidiary Beckman Coulter and cell morphology firm Scopio Labs announced on Wednesday a deal to expand Scopio's digital blood smear platforms.

Abbott said on Wednesday that COVID-19 testing demand has continued throughout its second quarter, driving its Diagnostics business revenues up 33 percent year over year.

On July 17, a reporter from People’s Daily Health Channel learned from Guangdong Academy of Sciences that Professor Wu Wenming, deputy director of the National Medical and Health Device Engineering Technology Research Center and scholar of the Hundred Talents Program of the Chinese Academy of Sciences

A study published in Gastroenterology finds that radiomics-based machine learning models may detect pancreatic cancer on prediagnostic CT scans substantially earlier than current methods for clinical diagnosis.

Delfi Diagnostics said on Monday that it has raised $225 million in a Series B financing, led by DFJ Growth with participation from Eli Lilly, Point72, Brown Advisory, Point Field Partners, Initiate Ventures, Open Field Capital, and PTX Capital.

Recently, Wondfo Biotech received the confirmation letter of in vitro diagnostic pre-qualification (PQ) issued by the World Health Organization (WHO). Recommended purchase list.

Chinese precision oncology firm Burning Rock Biotech and sequencing technology company MGI Tech have partnered to develop precision oncology services and products, the firms said earlier this month.

Roche announced on Monday that its Elecsys HCV Duo test for hepatitis C virus (HCV) received CE marking, and it is launching in countries accepting the regulatory approval.

Recently, during the first ZAODX World Cancer Early Screening Conference, Zhu Yeqing, CEO of New Horizon Health Ltd, said that according to CAIVD statistics, there are 58 listed enterprises with IVD business in China by the end of 2021, with a total revenue of 145.032 billion CNY

The director of Columbia University’s Center for Infection and Immunity talked about problems with antigen tests and the need for continued investment in COVID-19 testing.